Jill Sergison

FHI 360 | Associate Scientist

Jill Sergison is an associate scientist for FHI 360’s Contraceptive Technology Innovation Department and is also a practicing Certified Nurse-Midwife at Duke University. She has spent over a decade in clinical practice in the public sector, providing comprehensive women’s health care with an emphasis on family planning services. At FHI 360, she serves as the pharmacovigilance lead for clinical research studies across Phases I-IV in the field of contraception. She has also worked to increase access to long-acting family planning services both domestically and internationally. She holds an MA from New York University.